FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2992950226> ?p ?o ?g. }

• W2992950226 endingPage "A024" @default.
• W2992950226 startingPage "A024" @default.
• W2992950226 abstract "Abstract To facilitate interpretation of complex tumor sequencing data and clinical trial genomic eligibility criteria, we developed MatchMiner, an open-source platform to computationally match cancer patients to precision medicine clinical trials based on clinical and genomic features. MatchMiner supports two distinct workflows: (1) a patient-centric mode, in which an oncologist can find clinical trial matches for a specific patient, and (2) a trial-centric mode, in which a clinical trial investigator can identify and recruit patients for a specific trial. MatchMiner has been operational at Dana-Farber Cancer Institute since early 2017. There are currently 250+ trials curated in the system and genomic data from 24,000+ patients. Over 82% of living patients match to at least one open clinical trial, with an average of 6 trial matches per patient. At least 85 patients have enrolled on a clinical trial as a result of MatchMiner. The MatchMiner open-source software package is available through GitHub (https://github.com/dfci/matchminer). MatchMiner is a two-tier web application with a Python-based REST application programming interface (API) server and an AngularJS front-end. MatchMiner utilizes Security Assertion Markup Language (SAML)-based authentication and, when hosted behind a secure institutional firewall, is fully HIPAA-compliant. MatchMiner can connect to existing clinical systems, including clinical trial management systems for real-time trial status. To enable computational matching to clinical trials, we developed clinical trial markup language (CTML), a structured format to encode detailed information about a trial. CTML utilizes boolean logic to define clinical (e.g. cancer type), demographic (e.g. age) and genomic (e.g. specific mutations, copy number alterations, structural variants or mutational signatures) eligibility, which can be applied to individual arms of a trial. We recently refactored the core matching algorithm (the matchengine), which improves upon the original matchengine in several ways. While the original matchengine reported the reason for a patient-trial match, the refactored matchengine provides additional, more granular details. In addition, the original matchengine ran at the cohort level, matching all patients to all trials, whereas the refactored matchengine can also run against individual patients or trials, speeding up the matching process. The refactored matchengine is also easily extensible to match based on additional data types. In summary, we have defined a standard for encoding clinical trial information in a structured and computable form, and we have developed an open-source computational trial matching platform to support patient-specific trial identification as well as trial-specific patient recruitment. We are actively collaborating with clinical groups at Dana-Farber Cancer Institute to understand the role of MatchMiner in their clinical workflows, and we are committed to continuing to evolve MatchMiner to meet clinical needs. Citation Format: Tali Mazor, Rachel B Keller, Priti Kumari, James Lindsay, Eric Marriott, Andrea Ovalle, Ethan Siegel, Elizabeth H Williams, Joyce Yu, Michael Hassett, Ethan Cerami. MatchMiner: An open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; 2019 Oct 26-30; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2019;18(12 Suppl):Abstract nr A024. doi:10.1158/1535-7163.TARG-19-A024" @default.
• W2992950226 created "2019-12-13" @default.
• W2992950226 creator A5005519554 @default.
• W2992950226 creator A5006543894 @default.
• W2992950226 creator A5007672457 @default.
• W2992950226 creator A5011878961 @default.
• W2992950226 creator A5037241715 @default.
• W2992950226 creator A5054056965 @default.
• W2992950226 creator A5057799711 @default.
• W2992950226 creator A5064325544 @default.
• W2992950226 creator A5071787046 @default.
• W2992950226 creator A5078969152 @default.
• W2992950226 creator A5088348183 @default.
• W2992950226 date "2019-12-01" @default.
• W2992950226 modified "2023-09-27" @default.
• W2992950226 title "Abstract A024: MatchMiner: An open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials" @default.
• W2992950226 doi "https://doi.org/10.1158/1535-7163.targ-19-a024" @default.
• W2992950226 hasPublicationYear "2019" @default.
• W2992950226 type Work @default.
• W2992950226 sameAs 2992950226 @default.
• W2992950226 citedByCount "1" @default.
• W2992950226 countsByYear W29929502262023 @default.
• W2992950226 crossrefType "journal-article" @default.
• W2992950226 hasAuthorship W2992950226A5005519554 @default.
• W2992950226 hasAuthorship W2992950226A5006543894 @default.
• W2992950226 hasAuthorship W2992950226A5007672457 @default.
• W2992950226 hasAuthorship W2992950226A5011878961 @default.
• W2992950226 hasAuthorship W2992950226A5037241715 @default.
• W2992950226 hasAuthorship W2992950226A5054056965 @default.
• W2992950226 hasAuthorship W2992950226A5057799711 @default.
• W2992950226 hasAuthorship W2992950226A5064325544 @default.
• W2992950226 hasAuthorship W2992950226A5071787046 @default.
• W2992950226 hasAuthorship W2992950226A5078969152 @default.
• W2992950226 hasAuthorship W2992950226A5088348183 @default.
• W2992950226 hasConcept C126322002 @default.
• W2992950226 hasConcept C142724271 @default.
• W2992950226 hasConcept C163763905 @default.
• W2992950226 hasConcept C177212765 @default.
• W2992950226 hasConcept C19527891 @default.
• W2992950226 hasConcept C32220436 @default.
• W2992950226 hasConcept C41008148 @default.
• W2992950226 hasConcept C535046627 @default.
• W2992950226 hasConcept C60644358 @default.
• W2992950226 hasConcept C71924100 @default.
• W2992950226 hasConcept C77088390 @default.
• W2992950226 hasConcept C86803240 @default.
• W2992950226 hasConceptScore W2992950226C126322002 @default.
• W2992950226 hasConceptScore W2992950226C142724271 @default.
• W2992950226 hasConceptScore W2992950226C163763905 @default.
• W2992950226 hasConceptScore W2992950226C177212765 @default.
• W2992950226 hasConceptScore W2992950226C19527891 @default.
• W2992950226 hasConceptScore W2992950226C32220436 @default.
• W2992950226 hasConceptScore W2992950226C41008148 @default.
• W2992950226 hasConceptScore W2992950226C535046627 @default.
• W2992950226 hasConceptScore W2992950226C60644358 @default.
• W2992950226 hasConceptScore W2992950226C71924100 @default.
• W2992950226 hasConceptScore W2992950226C77088390 @default.
• W2992950226 hasConceptScore W2992950226C86803240 @default.
• W2992950226 hasIssue "12_Supplement" @default.
• W2992950226 hasLocation W29929502261 @default.
• W2992950226 hasOpenAccess W2992950226 @default.
• W2992950226 hasPrimaryLocation W29929502261 @default.
• W2992950226 hasRelatedWork W1712740190 @default.
• W2992950226 hasRelatedWork W1891303511 @default.
• W2992950226 hasRelatedWork W2002327913 @default.
• W2992950226 hasRelatedWork W2041266959 @default.
• W2992950226 hasRelatedWork W2407055211 @default.
• W2992950226 hasRelatedWork W2587175061 @default.
• W2992950226 hasRelatedWork W2731399752 @default.
• W2992950226 hasRelatedWork W2775411066 @default.
• W2992950226 hasRelatedWork W2778160167 @default.
• W2992950226 hasRelatedWork W4327569469 @default.
• W2992950226 hasVolume "18" @default.
• W2992950226 isParatext "false" @default.
• W2992950226 isRetracted "false" @default.
• W2992950226 magId "2992950226" @default.
• W2992950226 workType "article" @default.